Is Nasus Pharma Stock a good buy in 2025, according to Wall Street analysts?
The consensus among 1 Wall Street analyst covering (NYSEMKT: NSRX) stock is to Strong Buy NSRX stock.
Out of 1 analyst, 1 (100%) are recommending NSRX as a Strong Buy, 0 (0%) are recommending NSRX as a Buy, 0 (0%) are recommending NSRX as a Hold, 0 (0%) are recommending NSRX as a Sell, and 0 (0%) are recommending NSRX as a Strong Sell.
According to 1 Wall Street analyst that have issued a 1 year NSRX price target, the average NSRX price target is $22.00, with the highest NSRX stock price forecast at $22.00 and the lowest NSRX stock price forecast at $22.00.
The Wall Street analyst predicted that Nasus Pharma's share price could reach $22.00 by Sep 29, 2026. The average Nasus Pharma stock price prediction forecasts a potential upside of 196.9% from the current NSRX share price of $7.41.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.